Angiomax Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study
CONCLUSIONS: The anticoagulation strategy of bivalirudin bridging fondaparinux seems to be superior to that of bivalirudin bridging enoxaparin in patients with AMI undergoing PPCI.PMID:36817677 | PMC:PMC9897106 | DOI:10.5114/aoms/157287 (Source: Archives of Medical Science)
Source: Archives of Medical Science - February 23, 2023 Category: General Medicine Authors: Yanqing Guo Jingping Wang Zhixin Wang Li Li Jian An Source Type: research

Use of Bivalirudin for Chronic Total Occlusion Percutaneous Intervention: Insights From the PROGRESS-CTO Registry
CONCLUSION: Bivalirudin is infrequently used during retrograde CTO-PCI. While the incidence of adverse events was similar with unfractionated heparin, larger studies are needed to assess the safety of bivalirudin.PMID:36821841 (Source: The Journal of Invasive Cardiology)
Source: The Journal of Invasive Cardiology - February 23, 2023 Category: Cardiology Authors: Louis Verreault-Julien Bahadir Simsek Spyridon Kostantinis Athanasios Rempakos Judit Karacsonyi Taral N Patel Brian K Jefferson Mitul Patel Paul B Poommipanit Barry F Uretsky Khaldoon Alaswad Sevket Gorgulu Omer Goktekin Jaikirshan Khatri Dmitrii Khelimsk Source Type: research